AVBCC Annual Conference

Pathways Offer Providers a True Value Proposition

Caroline Helwick

July 2012, Vol 3, No 5 - AVBCC Annual Conference

Houston, TX—“The key question on everyone’s mind is, how do we monetize the value of pathways?” said Peter G. Ellis, MD, Deputy Director of Clinical Services and Associate Chief Medical Officer, University of Pittsburgh Cancer Centers, PA, at the Second Annual Conference of the Association for Value-Based Cancer Care. Clearly, Dr Ellis said, the use of pathways has internal practice value.

Pathways:

[ Read More ]

Tough Times for Small Oncology Practices

Caroline Helwick

July 2012, Vol 3, No 5 - AVBCC Annual Conference

Houston, TX—Hard times are getting even tougher for small oncology practices, said Leonard Natelson, Chief Executive Officer, Hematology/Oncology Associates, Rockland, NY, at the Second Annual Conference of the Association for Value-Based Cancer Care.

Hematology/Oncology Associates is an independent practice of 5 physicians, which in the Northeast region is considered “large,” Mr Natelson said. He cited 5 main challenges facing community oncologists today:

[ Read More ]

Involving the Patient in End-of-Life Care Decisions: Aetna’s Oncology Strategy

Caroline Helwick

July 2012, Vol 3, No 5 - AVBCC Annual Conference

Houston, TX—Payer-sponsored programs that promote appropriate endof- life care are beneficial to all stakeholders, according to Ira M. Klein, MD, MBA, Chief of Staff to the Chief Medical Officer, Aetna Oncology Strategy.

At the Second Annual Conference of the Association for Value-Based Cancer Care, Dr Klein discussed advancedcare directives and emphasized that the patient and family “should be at the center of what you do.”

[ Read More ]

Collaborate, Coordinate to Achieve Value in Oncology

July 2012, Vol 3, No 5 - AVBCC Annual Conference

Houston, TX—“Collaboration, coordination, data, and innovation are key to achieving value-based cancer care,” said Loreen M. Brown, MSW, Vice President of Reimbursement and Access Consulting, Xcenda, AmerisourceBergen Consulting Services.

Speaking at the Second Annual Conference of the Association for Value-Based Cancer Care, Ms Brown made the following points about the “evolving market” of oncology:

[ Read More ]

Evidence-Based Guidelines/Pathways Critical for Value-Based Benefit Design in Oncology

Caroline Helwick

July 2012, Vol 3, No 5 - AVBCC Annual Conference

Houston, TX—There is no question that evidence-based guidelines and pathways are critical to the success of value-based oncology, but not all stakeholders have an equal voice, said Craig Deligdish, MD, Chief Medical Officer at Oncology Resource Networks of America at the Second Annual Meeting of the Association for Value-Based Cancer Care. The goals inherent in value-based oncology benefit programs include:

[ Read More ]

Defining the Roles of Patient Navigation Can Remove Barriers to Quality Care

Caroline Helwick

July 2012, Vol 3, No 5 - AVBCC Annual Conference

Houston, TX—Patient navigation assures timely access to care for many patients, especially the medically underserved population, and it will soon become mandated for institutions accredited by the Commission on Cancer, reported Mandi Pratt-Chapman, MA, Associate Director of the Community Programs, Codirector of the Center for the Advancement of Cancer Survivorship, Navigation and Policy, George Washington Cancer Institute, Washington, DC, at the Second Annual Conference of the Association for Value-Based Cancer Care.

[ Read More ]

CareFirst Oncology Management Program Aims to Manage the “Entire Oncology Patient”

Caroline Helwick

June 2012, Vol 3, No 4 - AVBCC Annual Conference

Houston, TX—The Oncology Management Program at CareFirst Blue Cross Blue Shield (BCBS) continues to evolve, producing nearly 10% in cost-savings over prepathways practice, and ensuring that patients get more appropriate care, said Winston Wong, PharmD, Associate Vice President of Pharmacy Management at CareFirst BCBS, who described the program at the Second Annual Conference of the Association for Value-Based Cancer Care.

[ Read More ]

The Value of Level I Pathways at US Oncology

Caroline Helwick

June 2012, Vol 3, No 4 - AVBCC Annual Conference

Houston, TX—The use of the Level I Pathways Program at McKesson Specialty Health/US Oncology Network over the past 5 years has reduced treatment variability and resulting costs, according to Roy A. Beveridge, MD, chief medical officer, McKesson Specialty Health/US Oncology Network.

“We fundamentally believe that the use of these pathways significantly reduces the variation in patient care, and we have been able to demonstrate this,” Dr Beveridge said at the Second Annual Conference of the Association for Value-Based Cancer Care.

[ Read More ]

Reimbursement Strategies Must Be Patient-Centered

June 2012, Vol 3, No 4 - AVBCC Annual Conference

In an interview with the Association for Value-Based Cancer Care (AVBCC), Jennifer Malin, MD, PhD, Medical Director of Oncology at WellPoint, emphasized that patients should remain the central focus in novel or innovative reimbursement models.

AVBCC: Dr Malin, you have talked about the importance of keeping patient-centered care the focus of reimbursement strategies. How can this be done while still controlling cost?

[ Read More ]